Harpal Kumar

Currently a Chief Executive of Cancer Research UK

• Masters in Chemical Engineering from the University of Cambridge

• MBA as a Baker Scholar from Harvard Business School

• worked briefly as a research scientist with the UK Atomic Energy Authority

• worked for 4 years in the London office of McKinsey and Co, "advising pharmaceutical clients on strategic issues"

• CEO of The Papworth Trust "pioneering rehabilitation and housing services for people with acquired and congenital disabilities"

• founding CEO of Nexan Group, "a venture capital-backed medical device company, creating and marketing novel cardio-respiratory monitoring technologies to reduce premature mortality in patients with congestive heart failure"

• joined Cancer Research Technology Limited (CRT)

• became Chief Operating Officer of Cancer Research UK in July 2004

• Board Member of the National Cancer Research Institute and Chairman of the Gray Cancer Research Trust